AAAAAA

   
Results: 1-11 |
Results: 11
Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears
Authors: Bos, AB van Ballegooijen, M van den Akker-van Marle, ME Hanselaar, AGJM van Oortmarssen, GJ Habbema, JDF
Citation: Ab. Bos et al., Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears, AM J CLIN P, 115(6), 2001, pp. 851-855
Impact of systematic false-negative test results on the performance of faecal occult blood screening
Authors: Loeve, F Boer, R van Oortmarssen, GJ van Ballegooijen, M Habbema, JDF
Citation: F. Loeve et al., Impact of systematic false-negative test results on the performance of faecal occult blood screening, EUR J CANC, 37(7), 2001, pp. 912-917
Cost analysis of PAPNET-assisted vs. conventional pap smear evaluation in primary screening of cervical smears
Authors: Meerding, WJ Doomewaard, H van Ballegooijen, M Bos, A van der Graaf, Y van den Tweel, JG van der Schouw, YT Habbema, JDF
Citation: Wj. Meerding et al., Cost analysis of PAPNET-assisted vs. conventional pap smear evaluation in primary screening of cervical smears, ACT CYTOL, 45(1), 2001, pp. 28-35
Endoscopic colorectal cancer screening: a cost-saving analysis
Authors: Loeve, F Brown, ML Boer, R van Ballegooijen, M van Oortmarssen, GJ Habbema, JDF
Citation: F. Loeve et al., Endoscopic colorectal cancer screening: a cost-saving analysis, J NAT CANC, 92(7), 2000, pp. 557-563
Introduction: cervical cancer screening
Authors: Linos, A Riza, E van Ballegooijen, M
Citation: A. Linos et al., Introduction: cervical cancer screening, EUR J CANC, 36(17), 2000, pp. 2175-2176
Overview of important cervical cancer screening process values in EuropeanUnion (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness
Authors: van Ballegooijen, M van den Akker-van Marle, E Patnick, J Lynge, E Arbyn, M Anttila, A Ronco, G Dik, J Habbema, F
Citation: M. Van Ballegooijen et al., Overview of important cervical cancer screening process values in EuropeanUnion (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness, EUR J CANC, 36(17), 2000, pp. 2177-2188
Cervical cancer screening in The Netherlands
Authors: van Ballegooijen, M Hermens, R
Citation: M. Van Ballegooijen et R. Hermens, Cervical cancer screening in The Netherlands, EUR J CANC, 36(17), 2000, pp. 2244-2246
A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
Authors: Cuzick, J Sasieni, P Davies, P Adams, J Normand, C Frater, A van Ballegooijen, M van den Akker-van Marle, E
Citation: J. Cuzick et al., A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions, BR J CANC, 83(5), 2000, pp. 561-565
Withdrawing low risk women from cervical screening programmes - Conclusions cannot yet be drawn
Authors: van den Akker-van Marle, ME van Ballegooijen, M Boer, R van Oortmarssen, GJ Habbema, JDF
Citation: Me. Van Den Akker-van Marle et al., Withdrawing low risk women from cervical screening programmes - Conclusions cannot yet be drawn, BR MED J, 319(7201), 1999, pp. 58-58
Is PAPNET suitable for primary screening?
Authors: Kreuger, FA van Ballegooijen, M Doornewaard, H
Citation: Fa. Kreuger et al., Is PAPNET suitable for primary screening?, LANCET, 353(9162), 1999, pp. 1374-1375
The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening
Authors: Loeve, F Boer, R van Oortmarssen, GJ van Ballegooijen, M Habbema, JDF
Citation: F. Loeve et al., The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening, COMPUT BIOM, 32(1), 1999, pp. 13-33
Risultati: 1-11 |